M. Berteotti

发表

“Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine

A. Gori, M. Valgimigli, R. Marcucci, 2021, Platelets.

Monitoring antiplatelet therapy: where are we now?

R. de Caterina, F. Santilli, P. Calabrò, 2022, Journal of cardiovascular medicine.

Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease

A. Gori, I. Muraca, M. Berteotti, 2024, International journal of molecular sciences.

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry

B. Cosmi, E. Antonucci, G. Palareti, 2024, Journal of clinical medicine.

Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report

A. Gori, R. Marcucci, R. Valenti, 2023, International journal of molecular sciences.

The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists.

B. Giusti, A. Gori, A. Poggesi, 2024, Life sciences.

Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization

B. Giusti, A. Gori, E. Sticchi, 2024, Journal of clinical laboratory analysis.

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome

E. Antonucci, G. Palareti, P. Calabrò, 2021, Internal and Emergency Medicine.

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

B. Giusti, A. Gori, C. Di Mario, 2023, Journal of Thrombosis and Thrombolysis.

Whole Exome Sequencing in Vaccine-Induced Thrombotic Thrombocytopenia (VITT)

B. Giusti, A. Gori, E. Sticchi, 2024, BioMed research international.

Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.

E. Antonucci, D. Poli, M. Berteotti, 2024, International journal of cardiology.